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Background: Pulmonary hypertension may result in significant morbidity and mor-
tality after pediatric cardiac surgery. The objective of this study was to determine the
incidence and outcome of severe pulmonary hypertension, defined as a ratio of
pulmonary to systemic arterial pressure equal to or greater than 1.0, after cardiac
surgery in children.
Methods: Data from all children younger than 18 years who had undergone
cardiothoracic surgery from January 1, 1994, to December 31, 1998, were
examined. To find children with severe pulmonary hypertension, we reviewed
intensive care unit charts from patients who had been monitored with a pulmo-
nary artery catheter after the operation (n  151), had received mechanical
ventilation for more than 4 days after the operation (n  124), or had died in the
operating room or the intensive care unit (n  22). Intraoperative and postop-
erative measurements of mean pulmonary arterial pressure and postoperative
echocardiographic studies during the first 3 postoperative days were used to
select the children.
Results: During the study period, 1349 children (including 164 neonates and 511
infants, median age 12 months) underwent cardiac operations with an overall
perioperative mortality of 22 patients (1.6%). Twenty-seven children (2%,
median age 4.2 months) had severe pulmonary hypertension. Of these, 2 (7.4%)
died within 30 days of the operation, and 3 others (11%) died within a year
(median follow-up 53 months). Nitric oxide inhalation was used in 5 of the 27
cases, and it probably saved the life of 1 patient, may have helped in 1 case, and
had no discernible effect in 3 cases. Severe pulmonary hypertension was most
common after correction of complete atrioventricular septal defects (14%, n 
12/85). Thirteen of 131 children with Down syndrome (9.9%) had severe
pulmonary hypertension.
Conclusion: Severe postoperative pulmonary hypertension occurred after 2% of
the cardiac procedures and in most cases was managed successfully with
conventional treatment and had a favorable postoperative outcome. The low
incidence relative to previous reports may reflect the benefits of early correction
and improved intraoperative and postoperative care.
Postoperative pulmonary hypertension (PH) is a feared complicationafter heart surgery in children in whom increased pulmonary bloodflow, pulmonary venous obstruction, or both, have caused increasedpulmonary vascular resistance (PVR) and reactivity.1,2 The operativetrauma (eg, the endothelial injury caused by cardiopulmonary bypass[CPB])3 may further increase pulmonary vascular reactivity and create
a situation in which moderate postoperative stress dramatically increases PVR. In
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children with decreased right ventricular contractility, this
may result in acute right ventricular dilation, circulatory
collapse, and death.
It is probable that corrective surgery on younger children
(as is currently common practice) and improvements in
perfusion technology and perioperative care have both de-
creased the risk of PH and improved its outcome. Intraop-
erative ultrafiltration4 and selective decrease of PVR by
administration of inhaled nitric oxide (NO)5,6 have shown
promising results and are now routinely used in many
institutions. The creation of larger pediatric surgery pro-
grams may also have promoted early recognition and treat-
ment of PH, thus increasing the chances of a positive
outcome.7
This study was designed to determine the incidence and
clinical outcome of severe postoperative PH. This was de-
fined as increase in mean pulmonary arterial pressure (PAP)
to the level of systemic mean arterial pressure (MAP) or
greater.
Patients and Methods
Data on all children younger than 18 years who underwent cardiac
surgery in our institution during a 5-year period (January 1, 1994–
December 31, 1998) were retrieved from an intensive care data
base. The children were classified according to risk as recom-
mended by the Swedish National Board of Health and Welfare
(Table 1).8 Several patients underwent more than one operation,
but in the text and statistical assessment each operation is referred
to as one individual when not otherwise indicated.
To select children with or at risk for clinically important PH,
we studied all children who were monitored with pulmonary artery
catheters after the operation (n  151), who needed mechanical
ventilation longer than 4 postoperative days (n  124), or who
died in the operating room or intensive care unit (ICU, n  22).
Inclusion of children who had PAP continuously monitored after
the operation was likely to select most patients with severe PH,
because pulmonary artery catheters were routinely placed in chil-
dren deemed at risk for postoperative PH and in whom intraoper-
ative, postbypass cardiac pressure recordings indicated such a risk.
The pulmonary artery catheter was placed in the main pulmonary
TABLE 1. Pediatric heart operations according to the risk classification used by the Swedish National Health Institute
Group 1 Group 2A Group 2B Group 2C Group 3A Group 3B Group 3C
ASD secondary TOF AVSD Switch VSD plus
conduit
Fontan or TCPC Prematurity ( 1500 g)
ASD primary VSD plus AS TOF plus conduit Mustard Bidirectional
Glenn
Septation TAPVD plus UVH
VSD VSD plus PS Peripheral PS Senning PA plus VSD
(conduit)
Complex Glenn plus
(eg) VSD
enlargement
AVSD plus LV hypoplasia
PS, age 1 mo VSD plus
coarctation
DORV CTGA
(conduit)
Complex switch
plus (eg) VSD
closure
AS plus LV hypoplasia
AS, age  1 y ASD plus PAPVD Multiple VSDs PA plus IVS Complex DORV HLHS
Common atrium CTGA: VSD
closure
Critical PS Taussig-Bing
AS, age 1-12 mo AS, age 1 mo Unifocalization TAPVD, age 1 mo
MS, MR, age
1 y
Atrial
septectomy
Rastelli
TOF plus LAD
(Dx)
MR, MS,
age 1 y
Aortic root
reconstruction
Absent
pulmonary
valve
TAPVD, age
1 mo
Konno, Ross
AP window Truncus arteriosus
ALCAPA IAA
Cor
triatriatum
Damus-Kaye-
Stansel
Multiple
sternotomies,
if not 3B
AVSD plus TOF
Both general conditions and specific corrective procedures are listed. ASD, atrial septal defect; AVSD, atrioventricular septal defect; TOF, tetralogy of
Fallot; VSD, ventricular septal defect; TCPC, total cavopulmonary connection; AS, aortic stenosis; TAPVD, total anomalous pulmonary venous return; UVH,
univentricular heart; PS, pulmonary stenosis; PA, pulmonary atresia; LV, left ventricular; DORV, double-outlet right ventricle; CTGA, congenital corrected
transposition of the great arteries; PAPVD, partial anomalous pulmonary venous return; IVS, intact ventricular septum; HLHS, hypoplastic left heart
syndrome; MS, mitral stenosis; MR, mitral regurgitation; LAD (Dx), descent of left anterior descending coronary artery from right coronary artery; AP,
aortopulmonary; ALCAPA, anomalous left coronary artery from pulmonary artery; IAA, interrupted aortic arch.
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artery through the right ventricular infundibulum by the surgeon.
Recognizing that severe PH might also have occurred in children
without PAP catheters, but believing that severe PH would influ-
ence the postoperative course, we added the second and third
selection criteria. We thus reviewed 234 charts from which further
information was obtained. Seventy-eight children could be ex-
cluded because they had cardiac anomalies or had undergone
corrections not compatible with PH (eg, tetralogy of Fallot, pul-
monary stenosis or atresia, cavopulmonary connections, and the
Norwood procedure for hypoplastic left heart syndrome).
In the 156 children remaining after exclusions, the degree of
PH was classified as follows: as none or mild when mean PAP was
normal or only transiently elevated above 30 mm Hg, as moderate
when mean PAP exceeded 30 mm Hg on more than 3 occasions
after the operation but did not reach MAP levels, as severe when
mean PAP was at least as great as MAP, and as a PH crisis when
mean PAP equal to or greater than MAP was combined with a
decrease in MAP. In the text, severe PH and PH crisis are collec-
tively referred to as severe PH. In 122 of the 156 cases the
classification was guided by recorded data obtained from contin-
uous postoperative pulmonary arterial pressure monitoring. In the
cases of the 34 children without a pulmonary artery catheter, the
classification was based on pulmonary arterial or right ventricular
pressure measurements done in the operating room directly after
the surgical correction and on PAPs calculated from velocities of
the tricuspid or pulmonary valve regurgitations obtained by echo-
cardiographic Doppler studies in the ICU. It should be noted that
our selection criteria would discriminate children with severe PH
but give no information about the incidences of no PH, mild PH,
and moderate PH. In addition, we reviewed charts of all children
who had undergone correction of complete atrioventricular septal
defects (AVSDs, n  85) and children with Down syndrome (n 
131).
Perioperative or early mortality was defined as death occurring
during the operation or within 30 days of the operation. ICU
morbidity was expressed as duration of ventilatory support, dura-
tion of ICU stay, and number of registered complications. The
latter were classified as follows: circulatory complications were
noted when at least two inotropic drugs were used or a myocardial
infarction was diagnosed in the postoperative period; respiratory
complications were noted when stridor, obstruction, pulmonary
secretion, pulmonary edema, respiratory bronchitis, pneumotho-
rax, hemothorax, atelectasis, or pulmonary aspiration occurred and
required specific treatment; infectious complications were noted
when septicemia, wound infection, gastroenteritis, urinary tract
infection, or upper airway infection was diagnosed; renal compli-
cations were noted when hemodialysis or peritoneal dialysis was
used; and neurologic complications were noted when seizure,
cerebral infarction, cerebral bleeding, peripheral nerve palsy, or
clinical disturbance of consciousness or motor function was rec-
ognized.
To determine the risk of late death among children with severe
PH, follow-up data were obtained from the Swedish Census Bu-
reau and referring cardiology departments.
Intraoperative and Postoperative Routines
Anesthesia was induced with thiopental and maintained with low
to moderate doses of fentanyl, pancuronium, halothane or isoflu-
rane (inhaled concentration 1%), and nitrous oxide. All patients
received antibiotics intravenously, and children weighing less than
10 kg were given dexamethasone (1 mg/kg intravenously) imme-
diately after induction of anesthesia. CPB was managed with
nonpulsatile perfusion, a membrane oxygenator (Cobe VPCML;
Gambro AB, Stockholm, Sweden) and arterial line filters (Dideco
D733 or D736; Dideco Scandinavia, Malmo, Sweden). The circuit
was primed with crystalloids, mannitol, 20% albumin, buffer so-
lution tris(hydroxymethyl)aminomethane, and erythrocyte concen-
trate as needed to keep the hemoglobin concentration around 70
g/L. Cold crystalloid cardioplegia was used for all procedures
requiring aortic crossclamping. Ultrafiltration was introduced in
1996 and was used to decrease excessive fluid overload in the
bypass circuit for 10 to 15 minutes during rewarming in 84 of the
812 children operated on between 1996 and 1998.
After the operation, all patients were monitored with arterial
and central venous pressure catheters. Pulmonary artery catheters
were placed during the operation as indicated by intraoperative
measurements and preoperative studies. Arterial and central ve-
nous blood gas values were monitored as needed. Intraoperative
transesophageal echocardiography was used only occasionally.
Children with complex lesions or with hemodynamic instability
had transthoracic or transesophageal echocardiographic studies
done in the ICU.
All patients, including neonates and infants, were intubated
with cuffed endotracheal tubes, and intraoperative and postopera-
tive ventilation was maintained with volume- and pressure-con-
trolled ventilation, respectively, with a Siemens 900 C ventilator
(Siemens, Solna, Sweden). Patients for whom cardiac function
prohibited immediate discontinuation of CPB were usually treated
with low-flow CPB in the operating room until cardiac function
had improved. During the study period, postoperative mechanical
circulatory support was used for 1 patient with left ventricular
failure.
Children at risk for or with signs of postoperative PH were
sedated, received mechanical ventilatory support, and usually re-
ceived inotropic support (dobutamine, dopamine, or both) and
nitroglycerine infusion. PH crisis reactions were treated with man-
ual hyperventilation with 100% oxygen and intravenously admin-
istered opiates (usually fentanyl at 5-10 g/kg). NO inhalation is
not an approved medical therapy in Sweden and was therefore only
used when PH was considered life-threatening and other therapeu-
tic measures were ineffective. For patients with PH, mechanical
ventilation was continued until the PAP was well-controlled or
echocardiographic studies and the clinical course indicated that
myocardial function had recovered. After extubation and when
there was no longer any need for invasive monitoring or vasoactive
drugs, the child was transferred to the ward.
Statistical Analysis
Data were analyzed with the STATISTICA for Windows software
package (StatSoft Inc, Tulsa, Okla). Descriptive statistics are ex-
pressed as median and range. The Mann-Whitney U test was used
for comparisons of quantitative variables and followed by Bonfer-
roni correction when multiple comparisons were done. Qualitative
variables were compared with the 2 test.
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Results
During the study period, a total of 1349 patients underwent
cardiac procedures. Twenty-two (1.6%) died within 30 days
of surgery. The mortalities in different age and risk groups
are shown in Table 2.
Severe PH was observed in 27 patients, for an overall
incidence of 2.0% (n 27/1349). PH crises occurred in 9 of
these children (0.7%, n  9/1349; Table 3). The PH clas-
sification was based on direct measurements of PAP in 26
cases and on intraoperative pressure measurements and
postoperative Doppler measurements in 1 case. Two infants
with severe PH died within 30 days (7.4%, n  2/27). Both
deaths occurred immediately after correction. The infants, a
5-week-old girl with a ventricular septal defect and bilateral
pulmonary venous stenosis and a 3-month-old boy with an
AVSD, had suprasystemic right ventricular pressure, tricus-
pid insufficiency, and severe right to left shunting with a
transcutaneous oxygen saturation of 40% to 80%. At the end
of the correction both infants had severe PH, and inotropic
support and prolonged mechanical support with low-flow CPB
were both ineffective. Postmortem examination showed ad-
vanced muscle hypertrophy in the small arteries and intimal
proliferation and small vessel occlusion in the pulmonary cir-
culation.
Children with severe PH were younger, needed longer
postoperative ventilation, stayed longer in the ICU, and had
more circulatory and renal complications than did the other
children (Table 4). Inhalation of NO was used in 5 cases of
severe PH. Inhaled NO was tried for the 2 children with PH
crises who died during the operation after the surgical
correction, but it had no effect on PAP. In 1 case NO
inhalation was given before the operation, but the patient
could easily be weaned during the operation. NO inhalation
probably saved the life of 1 patient, may have helped in 1
case, and had no discernible effect in 3 cases.
The median follow-up for the 25 surviving children with
severe PH was 53 months (range 13-70 months). Most
patients (n  17/27) had signs of residual PH on echocar-
diographic studies before discharge from our hospital (tri-
cuspid insufficiency with a maximum velocity 2.5 m/s).
Three children (n  3/27, 11%) 4 months, 4 months, and 7
weeks old at operation died 205, 211, and 218 days after the
operation, respectively. All 3 had been in need of long ICU
treatment after the initial operation (24, 19, and 49 days,
respectively). Two of these children had a hypoplastic left
ventricle, a hypoplastic mitral valve, or mitral stenosis and
persistent severe PH and needed prolonged and repeated
hospitalizations for the remainder of life. One child had
undergone correction with two-patch technique for an un-
balanced AVSD and had normal PAP at discharge from the
hospital (maximum velocity in tricuspid insufficiency of 2
m/s) but died suddenly 6 months later in what was inter-
preted as arrhythmia.
There was clear overrepresentation of children with
AVSD (n  12) and children with Down syndrome (n 
12) among those with severe PH. These two groups were
therefore studied more closely (Tables 5 and 6). Of the 85
children with complete AVSD who underwent biventricular
correction during the study period, records of 56 had been
retrieved with the selection criteria, whereas those of 29,
because of lack of pulmonary arterial catheter monitoring
and an uncomplicated postoperative course, had not. The
charts of the latter 29 patients were reviewed, and the
patients were classified. None of these patients had signs of
severe PH and were therefore classified as having none or
moderate PH. Thus of the 85 children, 86% (n 73/85) had
no, mild, or moderate PH, 14% (n  12/85) had severe PH,
and 4.7% (n  4/85) had PH crises. Children with AVSD
who had severe PH had longer perfusion and aortic cross-
clamp times, needed longer mechanical ventilation, and
spent longer time in the ICU than did those who had no,
mild, or moderate PH, but there was no difference in mor-
TABLE 2. Cardiac surgery in Lund during the study period of January 1, 1994, through December 31, 1998
Group
Premature
infants* 0-1 mo 1-12 mo 1-17 y Total Operative
riskAll Deaths† All Deaths† All Deaths† All Deaths† All Deaths†
1 0 0 0 0 130 0 256 1 386 1 0.3%
2A 0 0 3 0 91 0 74 0 168 0 0.0%
2B 0 0 13 0 123 2 34 0 170 2 1.2%
2C 1 0 47 1 2 0 1 0 51 1 2.0%
3A 1 0 16 0 84 4 120 0 221 4 1.8%
3B 3 0 44 2 54 2 163 0 264 4 1.5%
3C 4 0 32 5 27 4 20 1 83 10 12.0%
Transplantation 0 0 0 0 0 0 6 0 6 0 0.0%
Total 9 0 (0.0%) 155 8 (5.2%) 511 12 (2.3%) 674 2 (0.3%) 1349 22 1.6%
The patients are classified according to risk as recommended by the Swedish National Health Institute (see Table 1).
*Infants weighing less than 2500 g.
†Perioperative death, within 30 days after operation.
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tality or age at operation between the two groups (Table 5).
The early mortality among children with AVSD was 2.4%
(n  2/85).
Of the 12 children with AVSD who had severe PH, 10
also had Down syndrome. Down syndrome may, however,
be an independent risk factor for severe PH. Of the 131
patients with this diagnosis, 59 had been identified as “at-
risk patients.” None of the other 71 patients had a postop-
erative course complicated by severe PH. The incidence of
severe PH among children with Down syndrome was thus
9.9% (n  13/131) and the early mortality was 0.8% (n 
1/131). As could be expected, children with Down syn-
drome who had severe PH needed longer mechanical ven-
tilation and ICU treatment and had longer perfusion and
aortic crossclamp times than did children with Down syn-
drome who had no, mild, or moderate PH, but the ages at
operation were not different between the two subgroups
(Table 6).
Discussion
In this retrospective study, we found a 2% incidence of
severe PH and a 0.7% incidence of PH crisis after cardiac
surgical procedures. These rates are lower than has been
reported earlier. One obstacle when comparing the inci-
dence of PH, however, is that the criteria for PH, most
notably the criteria for clinically important or severe PH,
vary in the literature. We chose to define severe PH as a
mean PAP that rose to equal or exceed MAP, because we
were interested in selecting patients with a PAP increase
that had a clear impact on postoperative care and outcome.
Because we did not measure postoperative PAP in all chil-
dren, but only in those believed to be at risk for postoper-
ative PH, we cannot exclude the possibility that some chil-
dren with transient increases in PAP, even to suprasystemic
levels, may have been missed. If this did occur, however,
the clinical consequences were obviously not dramatic, be-
cause none of these children died or were in need of more
TABLE 3. Patients with PH crisis
Age at
operation Preoperative diagnosis Operation
Postoperative
course Survival
5 wk Bilateral pulmonary
venous stenosis plus
VSD
Resection of bilateral
pulmonary vein
stenosis plus suture
of VSD
Died in operating
room
Died d 0
7 wk Hypoplastic LV plus
hypoplastic mitral
valve (MS) plus ASD
plus Down syndrome
Exploration of mitral
valve plus closure of
ASD
Possibly too small
LV,
postoperative
pneumonia
Died d 218
3 mo Complete AVSD Correction of AVSD
with 2-patch
technique
Died in operating
room
Died d 0
3 mo TGA plus VSD Arterial switch
operation plus
closure of VSD with
patch plus resuture
of coronary artery
LV failure
4 mo Unbalanced AVSD plus
Down syndrome
Correction of AVSD
with 2-patch
technique
Possibly
arrhythmia
Died d 205
6 mo Complete AVSD plus
Down syndrome
Correction of AVSD
with 2-patch
technique
LV failure
13 mo Supravalvular MS plus
parachute mitral
valve plus previous
VSD operation
Resection of
supravalvular
membrane plus
commissurotomy
MR, reoperated,
with no MR or
PH afterward
2 y Unbalanced AVSD plus
Down syndrome
Correction of AVSD
with 2-patch
technique
3 y Congenital MR plus left
pulmonary vein
stenosis
Revalvuloplasty of
mitral valve
MR
VSD, Ventricular septal defect; AVSD, atrioventricular septal defect; LV, left ventricle; MS, mitral stenosis; ASD, atrial septal defect; TGA, transposition of
great arteries; MR, mitral regurgitation.
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than 96 hours of postoperative mechanical ventilation. We
thus believe that our study design did select all children with
clinically important PH. We also made a clear distinction
between children with PH who had a sustained stable MAP
and those who did not (PH crisis). In the literature critical or
severe PH is usually defined as a PAP that is close to or
exceeds MAP, although some have called this a “minor PH
crisis” or a “PH event.”5,6,9-11 As was the case in this study,
the designation PH crisis has mostly been reserved for
situations in which PAP acutely exceeds MAP and is ac-
companied by a fall in MAP, a fall in arterial or venous
oxygen saturation, or both.
Previous studies have thus reported both higher inci-
dences of and higher mortalities associated with severe PH.
In 1991, Hopkins and colleagues12 prospectively investi-
gated the incidence of PH crisis and observed a 10 times
greater incidence (7.6%) than we did. Moreover, they found
a mortality of 54.5% among children with PH crisis,12 as
compared with 22.2% (n  2/9) among our patients. Our
mortality among patients with severe PH—7.4% (n  2/27)
died during the first 30 days after the operation—is also
lower than that observed by Bando and coworkers.9 These
authors used a more generous definition of severe PH (with
a PH event defined as PH crisis or systolic PAP more than
TABLE 4. Intraoperative and postoperative characteristics of the total study population and of children with severe PH
All children Severe PH P value
No. of patients 1349 27
Perioperative deaths (No.) 22 (1.6%) 2 (7.4%)
Perfusion time (min, median and range) 81 (11-650) 124 (44-620) .001
Aortic crossclamp time (min, median and
range)
35 (53-172) 71 (4-172) .001
Postoperative mechanical ventilation (d,
median and range)
0.6 (0-86.6) 7.7 (0.7-45.6) .001
Time in ICU (d, median and range) 3.0 (1.0-87.0) 9.0 (0-48) .001
Age at operation (mo, median and range) 11.9 (0.03-219) 4.2 (0.03-59) .05
Complications
Circulatory 12.8% 33.3% .001
Respiratory 14.1% 25.9% .073
Renal 4.8% 18.5% .001
Infectious 3.2% 7.4% .474
Neurologic 2.5% 0% .031
TABLE 5. Clinical findings in children operated for complete AVSD
No PH, mild PH, or moderate PH
(n  73) Severe PH (n  12)
P valueMedian Range Median Range
Time on ventilator (d) 0.9 0.1-63.7 7.3 0-36.3 .001
Perfusion time (min) 109 70-333 138 101-540 .003
Aortic crossclamp
time (min)
69 34-123 76 60-88 .028
Time in ICU (d) 3 2-64 9 1-42 .001
Age at operation (mo) 4.2 0.6-81 4.2 3.3-26 .435
TABLE 6. Clinical findings in children with Down syndrome
No PH, mild PH, or moderate
PH (n  118) Severe PH (n  13)
P valueMedian Range Median Range
Time on ventilator (d) 0.8 0-63.7 7.7 0.9-44.6 .001
Perfusion time (min) 92 22-301 129 44-325 .01
Aortic crossclamp time (min) 49 0-117 76 4-88 .035
Time in ICU (d) 3 2-64 12 4-49 .001
Age at operation (mo) 6.2 0.6-219 4.2 1.3-26 .197
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50% of MAP continuing for 6 hours after repair) and
found a mortality of 18.5% (n  10/54) in 1980 through
1984 and a mortality of 35.5% (n  11/31) in 1990 through
1994.9
Study Population and Incidence of Severe Pulmonary
Hypertension
We think that it is unlikely that our lower incidence and
mortality were due to the differences in study design.
Rather, they may reflect the differences in the population of
children admitted to surgery and possibly recent improve-
ments in intraoperative and postoperative care. The two
factors that are most likely to influence the incidence of
severe PH are probably the diagnosis and the age of the
patient at surgery. The diagnoses and age distribution of our
patients (Tables 1 and 2) are probably representative of the
situation in other Scandinavian and northern European cen-
ters, but the incidence would be expected to be higher in
institutions that operate on a relatively larger number of
patients with diagnoses associated with PH or in those with
patients operated on later, with more advanced disease. In
addition to AVSD, the diagnoses most commonly and tra-
ditionally associated with severe PH are transposition of the
great arteries, truncus arteriosus, total anomalous pulmo-
nary venous drainage, and ventricular septal defect.9,12 Our
study design did not allow a multiple regression risk anal-
ysis, but our findings suggest that the presence of pulmonary
venous obstruction—as can be seen in patients with pulmo-
nary venous stenosis, mitral stenosis or regurgitation, and
elevated left atrial pressure as a result of left ventricular
failure—was a more important predictor of severe PH than
was the diagnosis itself. When we reviewed the other 20
perioperative deaths during the study period, we found that
most of them were of neonates and infants with the most
complex cardiac defects. An increased PVR may have
played an important role in several of these deaths, making
it clear that subsystemic increases in PAP are not harmless.
Clearly, moderate increases in PVR and PAP may be life
threatening in patients with a Fontan circulation or in pa-
tients with a failing right ventricle. In this study the median
age of infants with severe PH was 4.2 months, and only 4 of
the patients were more than 1 year old. This reflects the
structure of the Swedish health system, which promotes
early diagnosis and treatment, so that rather few patients are
referred at a late stage of their disease.
Intraoperative and Postoperative Care
Early identification and treatment of PH and improvements
in intraoperative and postoperative treatment may also have
contributed to the lower incidence and more effective treat-
ment of severe PH. One would like to believe that the
increase in caseload and experience that occurred after the
centralization of Swedish pediatric cardiac surgery in 1993,
which increased the population of the Lund University
Hospital referral area to approximately 5 million inhabit-
ants, promoted early detection and improved outcome,13 but
the number of patients with severe PH was too small to
detect any clear changes in the annual incidences or out-
comes during the study period.
CPB induces pulmonary endothelial cell injury and pul-
monary dysfunction, probably from hypoperfusion of the
lung during CPB or activation of the systemic inflammatory
response, which exacerbates the reactivity of the pulmonary
vascular bed. This may result in inhibition of NO produc-
tion3 and increase in the production of endothelin 1 after
CPB.14,15 Several interventions, including dexamethasone,
ultrafiltration, aprotinin, leukocyte depletion, antioxidants,
and heparin-coated circuits,4,16-19 may decrease the inflam-
matory response during CPB, but more studies are needed to
clarify whether their use is really cost-effective. Of these,
only dexamethasone and ultrafiltration were used in this
study.
Treatment for PH can be regarded as a bridge until the
increase in PVR has subsided or the right ventricle is able to
cope with the increased PVR. In our study no patient with
severe PH died in the ICU, indicating that treatment today
is usually successful, albeit long and sometimes challeng-
ing. As is the case in most ICUs, our treatment (see the
Methods section) is only partially based on scientific data.
Rather, it reflects local tradition and our own experiences
and biases. Inhalation of NO can selectively decrease mean
PAP and improve arterial and venous oxygen saturation,
and it is the preferred treatment for severe postoperative PH
in many centers.6,10,11 In Sweden, NO treatment is only
allowed when conservative treatment is ineffective and the
patient has life-threatening PH. In this study severe PH
could usually be managed with conventional therapies. NO
inhalation was only used for 5 patients with life-threatening
PH. One patient was probably saved by the treatment, but
neither of the 2 children with PH-associated death had any
response. We can, of course, not exclude the possibility that
a more liberal use of NO inhalation would have improved
postoperative care and shortened the ICU stay. On the other
hand, a more generous use of NO might have created a risk
for overtreatment and prolonged ICU stay. We believe that
the function of the right ventricle is an important guide for
treatment and weaning from mechanical ventilation, and we
usually do not await normalization of PAP before extuba-
tion. The failure of the operation to achieve a competent
mitral valve is an important factor leading to postoperative
PH and may be a predictor of outcome. Most children with
mitral regurgitation could be weaned from the ventilator
after improved medical treatment and in some cases after
several trials of extubation.
All our children with PH crises had multiple episodes of
high PAP. In other institutions, some of them would perhaps
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have been candidates for extracorporeal membrane oxygen-
ation. Again, it should be noted that conservative ICU
treatment was successful; none of our patients with severe
PH died in the ICU. Obviously we cannot exclude the
possibility that extracorporeal membrane oxygenation
would have saved the lives of the 2 infants who died in the
operating room, but their responses during prolonged low-
flow CPB make this unlikely. When it comes to other
measures that may be helpful for patients with PH, Bando
and coworkers9 found that -blockers and continuous mon-
itoring of systemic venous saturation were both beneficial.
Neither was used in our case series.
Although the immediate outcome of patients with severe
PH were good, all had long ICU stays (Table 4). We thus
expected significant late morbidity and mortality in the
group. The rather low late mortality (n  3/27) was there-
fore encouraging.
Incidence and Outcome Among Children with AVSD
and with Down Syndrome
Complete AVSD was the most common diagnosis among
children with severe PH. The high incidence of PH in this
patient group may have been due to the combination of
pulmonary overcirculation and increased pulmonary venous
pressure seen with this anomaly. In addition, 10 of the 12
children with severe PH also had Down syndrome, which
entails a higher incidence of airway obstruction and noctur-
nal hypoxia.20,21 Children with complete AVSD who show
clinically important PH have been reported to have a high
mortality rate (55%).9 This is in contrast to the 17% ob-
served in this study. Only 1 of the 12 children with complete
AVSD who had suprasystemic PAP (7.7%) died, and the
total mortality in the AVSD group was only 2.4% (n 
2/85), indicating that further improvement in the treatment
of this category of children has occurred.22,23
Down syndrome is often associated with congenital heart
disease, and data suggest that children with Down syndrome
have a propensity toward early development of severe dam-
age to the pulmonary vascular bed.24,25 In our study children
with Down syndrome were equally distributed among the
different grades of PH and had a mortality of 0.8% (n 
1/131). Thus children with Down syndrome who underwent
cardiac surgery had a survival similar to that of a compa-
rable group of children without Down syndrome. This was
also true for children with AVSD; children with AVSD and
Down syndrome did not have a higher mortality than did
other children with AVSD. This differs from the findings of
Reller and Morris,26 who reported a 13% mortality for
children with Down syndrome and complete AVSD but a
mortality of only 5% for other children with AVSD. We
believe that early correction of AVSD in children with
Down syndrome is an important strategy to avoid postop-
erative PH. All children with AVSD now undergo correc-
tion before the age of 3 to 4 months.
In conclusion, the incidence of systemic or suprasys-
temic PAP was 2% in our patient population, and most
children who had such reactions had favorable postopera-
tive outcomes. Only 2 of the 22 deaths during the study
period were related to PH crisis. Long-term survival was
surprisingly good, and late deaths occurred in only 3 cases
of ventricular imbalance. We believe that early surgery, the
preoperative condition, and the local referral pattern are
important contributing factors for the low incidence of
severe PH and PH crisis.
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